Pharmafile Logo

Sanofi

The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Sanofi in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Sanofi.

Recent articles on PMLiVE featuring Sanofi

- PMLiVE
Sanofi announces phase 3 study data for infantile-onset Pompe disease

Pompe disease is a rare, progressive neuromuscular disease, with infantile onset being the most aggressive form

- PMLiVE
Sanofi’s Cenrifki approved in Europe for secondary progressive MS without relapses

SPMS is a debilitating stage of MS where patients experience increasing levels of disability

- PMLiVE
Lundbeck appoints Tarek Samad as EVP, Head of Research & Development

Samad previously held senior research leadership positions at Immunitas Therapeutics, Sanofi and Pfizer

- PMLiVE
Sanofi appoints Paulo Fontoura as Global Head of R&D

Fontoura previously held senior leadership roles at Xaira Therapeutics and Roche

- PMLiVE
Sanofi’s Sarclisa approved by MHRA as UK’s first anti-cancer treatment given via on-body injector

It is the first anticancer treatment in the UK and globally to be administered this way and a first in multiple myeloma

- PMLiVE
Gates Medical Research Institute appoints Charles Wells as Chief Medical Officer and Head of Medical Development

Wells previously served in executive leadership roles at Sanofi and Evotec

- PMLiVE
adelo acquires Dot I/O Health, with Nigel Breakwell becoming Managing Partner

Nigel Breakwell was formerly Joint CEO of Edelman London and MD of WCG

- PMLiVE
Sanofi’s Tzield gets expanded FDA approval for early-stage type 1 diabetes

The treatment can be used to delay the onset of clinical type 1 diabetes

- PMLiVE
Evotec appoints Ingrid Müller as Chief Operating Officer

Most recently, Müller held senior international leadership roles at CureVac, Sanofi and Fresenius Kabi

- PMLiVE
Poolbeg Pharma appoints Adrian Kilcoyne to Scientific Advisory Board

Kilcoyne previously held senior roles at AstraZeneca, Celgene, Sanofi, Roche and Eli Lilly

- PMLiVE
N4 Pharma appoints David Solomon as CEO

The company is to be renamed Thalia Therapeutics to reflect its strategic transition

- PMLiVE
Sanofi announces positive results for venglustat in type 3 Gaucher disease

There are currently no approved treatments for the neurological symptoms of this disease

Data provided by GlobalData

GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.

Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.

To find out more about how our research and insights can help you, please visit  https://www.globaldata.com/who-we-are/why-globaldata/

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links